Source: Memórias do Instituto Oswaldo Cruz. Unidade: FMRP
Subjects: MIOCARDIOPATIA CHAGÁSICA, DOENÇA CRÔNICA, RESULTADO DE TRATAMENTO, TRIPANOSSOMICIDAS, TRYPANOSOMA CRUZI
ABNT
RASSI JÚNIOR, Anis e MARIN NETO, José Antonio e RASSI, Anis. Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial. Memórias do Instituto Oswaldo Cruz, v. 112, n. 3, p. 224-235, 2017Tradução . . Disponível em: https://doi.org/10.1590/0074-02760160334. Acesso em: 10 maio 2024.APA
Rassi Júnior, A., Marin Neto, J. A., & Rassi, A. (2017). Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial. Memórias do Instituto Oswaldo Cruz, 112( 3), 224-235. doi:10.1590/0074-02760160334NLM
Rassi Júnior A, Marin Neto JA, Rassi A. Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial [Internet]. Memórias do Instituto Oswaldo Cruz. 2017 ; 112( 3): 224-235.[citado 2024 maio 10 ] Available from: https://doi.org/10.1590/0074-02760160334Vancouver
Rassi Júnior A, Marin Neto JA, Rassi A. Chronic Chagas cardiomyopathy: a review of the main pathogenic mechanisms and the efficacy of aetiological treatment following the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT) trial [Internet]. Memórias do Instituto Oswaldo Cruz. 2017 ; 112( 3): 224-235.[citado 2024 maio 10 ] Available from: https://doi.org/10.1590/0074-02760160334